Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Dec 11;107(1):53–59. doi: 10.1111/cas.12839

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Suppression of prostate cancer growth by the treatment with Bauhinia purprea agglutinin (BPA)‐PEG‐LPDOX. Therapeutic effect of BPA‐PEG‐LPDOX on DU145 cancer‐bearing mice. PEG‐LPDOX or BPA‐PEG‐LPDOX (2 mg/kg/day as DOX dosage) was i.v. injected via a tail vein into DU145 cancer‐bearing mice (n = 4–6) once a week for a total of three treatments (day 29, 36 and 43). The tumor volume was monitored daily starting after day 22. Data are shown as the mean. SD are shown with bars at day 51. Significant differences are shown with asterisks (*P < 0.05; **P < 0.01, Tukey HSD).